retatrutide telehealth Retatrutide Phase 3: 60% Achieved

The clinical efficacy of semaglutide and tirzepatide has led to these drugs being among the most commonly prescribed in the USA, with an estimated one in eight people having used a GLP1 receptor agonist medication 4

These combination products can be part of a comprehensive approach to managing constipation alongside other GLP-1 side effects

These medications exert (in)direct hepatic actions by reducing steatosis, attenuating inflammation, and potentially reversing fibrosis, while simultaneously addressing systemic metabolic abnormalities including excessive obesity, insulin resistance, and cardiovascular risk

AI also helps with demand forecasting and speeds up drug development, which helps manufacturers improve market efficiency and streamline supply chains

Our approach is holistic, focusing on a combination of diet, exercise, behavioral changes, and, when suitable, medication to ensure the best possible outcomes for our patients